Ultrasonic gallbladder function in chronic kidney disease: Does predialysis, hemodialysis, or CAPD affect it?

Renal Failure

Volumn 27, Issue 6, 2005, Pages 677-681

  Bektas, Ahmet ^a   Belet, Umit ^a   Kelkitli, Engin ^a   Bakir, Tulay ^a   Acikgoz, Abdullah ^a   Akpolat, Tekin ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Chronic kidney disease; Gallbladder volume; Gallstone; Motility; Ultrasound

Indexed keywords

ALBUMIN; BIOCHEMICAL MARKER; CALCIUM; CHOLESTEROL; CREATININE; NITROGEN; PARATHYROID HORMONE; PHOSPHORUS; TRIACYLGLYCEROL; UREA;

ADULT; AGE; ALBUMIN BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; BILE COMPOSITION; BODY MASS; CALCIUM BLOOD LEVEL; CALCULATION; CHOLESTEROL BLOOD LEVEL; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GALLBLADDER FUNCTION; GALLBLADDER MOTILITY; GALLSTONE; GENDER; GLOMERULOSCLEROSIS; HEART EJECTION FRACTION; HUMAN; INTERMETHOD COMPARISON; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTPRANDIAL STATE; PREOPERATIVE CARE; PREVALENCE; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND; UREA NITROGEN BLOOD LEVEL; UROLITHIASIS;

ADULT; AGE DISTRIBUTION; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLELITHIASIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROBABILITY; REFERENCE VALUES; RENAL DIALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TURKEY; ULTRASONOGRAPHY, DOPPLER;

EID: 28644447021     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500234949     Document Type: Article

References (31)

1. Gallstones and inflammatory gallbladder disease. In: Sherlock S, Dooley J, eds. Disease of the Liver and Biliary System. 11th ed. UK: Blackwell Science, 2002:597.
2. Beyler AR, Yaşa MH, Palabiyikoǧlu M, et al. Safra kesesi taşlarinda epidemiyolojik özellikler ve operasyon orani. Turk J Gastroenterol. 1996;7(suppl 1):B97.
3. Del Olmo JA, Garcia F, Serra MA, Maldonado L, Rodrigo JM. Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol. 1997;32(10):1061-1065.
4. Kalayci AG, Albayrak D, Güneş M, Incesu L, Agaç R. The incidence of gallbladder stones and gallbladder function in beta-thalassemic children. Acta Radiol. 1999;40(4):440-443.
5. Li Vecchi M, Soresi M, Cusimano R, et al. Prevalence of biliary lithiasis in a Sicilian population of chronic renal failure patients. Nephrol Dial Transplant. 2003;18(11):2321-2324.
6. Badalamenti S, DeFazio C, Castelnovo C, et al. High prevalence of silent gallstone disease in dialysis patients. Nephron. 1994;66(2):225-227.
7. Altiparmak MR, Pamuk ÖN, Pamuk GE, et al. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey. Am J Gastroenterol. 2003;98(4):813-820.
8. Korzets Z, Golan E, Ben-Chitrit S, et al. Prevalence of cholelithiasis in non-diabetic haemodialysis and continuous ambulatory peritoneal dialysis patients. Nephron. 1998;78(1):44-47.
9. Paydaş S, Seyrek N, Görkel Y, Sagliker Y. Prevalence of cholelithiasis in patients with end-stage renal disease. Nephron. 1996;72(1):115-116.
10. Gladziwa U, Wagner S, Riehl J, Sieberth HG. Prevalence of cholelithiasis in haemodialysis patients. Nephrol Dial Transplant. 1993;8(12):1397-1400.
11. Hojs R. Cholecystoliyhiasis in patients with end-stage disease treated with haemodialysis: a study of prevalence. Am J Nephrol. 1995;15(1):15-17.
12. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int. 1981;20(2):246-253.
13. Pauletzki J, Althaus R, Holl J, Sackmann M, Paumgartner G. Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology. 1996;111(3):765-771.
14. Levey AS, Coresh J, Balk E, et al, National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-147.
15. Dodds WJ, Groh WJ, Darweesh RM, Lawson TL, Kish KSM, Kern MK. Sonographic measurement of gallbladder volume. AJR. 1985;145(5):1009-1011.
16. Donovan JM. Physical and metabolic factors in gallstone pathogenesis. Gastroenterol Clin North Am. 1999;28(1):75-97.
17. Dowling RH. Pathogenesis of gallstones. Aliment Pharmacol Ther. 2000;14(suppl 2):39-47.
18. Van Bodegraven AA, Böhmer CJM, Manoliu RA, et al. Gallbladder contents and fasting gallbladder volumes during and after pregnancy. Scand J Gastroenterol. 1998;33(9):993-997.
19. Tandon RK, Jain RK, Garg PK. Increased incidence of biliary sludge and normal gallbladder contractility in patients with high spinal cord injury. Gut. 1997;41(5):682-687.
20. De Santis A, Attili AF, Corradini SG, et al. Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology. 1997;25(4):787-790.
21. Chapman BA, Wilson IR, Frampton CM, et al. Prevalance of gallbladder disease in diabetes mellitus. Dig Dis Sci. 1996;41(11):2222-2228.
22. Makino I, Chijiiwa K, Higashijima H, et al. Rapid cholesterol nucleation time and cholesterol gallstone formation after subtotal or total colectomy in humans. Gut. 1994;35(12):1760-1764.
23. Inoue K, Fuchigami A, Higashide S, et al. Gallbladder sludge and stone formation in relation to contractile function after gastrectomy. Ann Surg. 1992;215(1):19-26.
24. Veysey MJ, Thomas LA, Mallet AI, et al. Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones. Gut. 1999;44(5):675-681.
25. Greenstein SM, Katz S, Sun S, et al. Prevalence of asymptomatic cholelithiasis and risk of acute cholecystitis after kidney transplantation. Transplantation. 1997;63(7):1030-1032.
26. Mareckova O, Skala I, Marecek Z, et al. Bile composition in patients with chronic renal insufficiency. Nephrol Dial Transplant. 1990;5(6):423-425.
27. Gladziwa U, Wagner S, Kock R, Mann H, Sieberth HG. Sonographic evaluation of gallbladder motility in patients with end-stage renal disease on haemodialysis. Nephrol Dial Transplant. 1992;7(8):840-843.
28. Liedberg G. The effect of vagotomy on gallbladder and duodenal pressures during rest and stimulation with cholecystokinin. Acta Chir Scand. 1969;135(8):695-700.
29. Persson CG. Adrenoreceptors in the gallbladder. Acta Pharmacol Toxicol (Copenh). 1972;31(3):177-185.
30. Yau WM, Makhlouf GM, Edwards LE, Farrar JT. Mode of action of cholecystokinin and related peptides on gallbladder muscle. Gastroenterology. 1973;65(3):451-456.
31. Lin TM. Actions of gastrointestinal hormones and related peptides on the motor function of the biliary tract. Gastroenterology. 1975;69(4):1006-1022.